NCT07086846

Brief Summary

This study will be conducted to compare the effect of myofascial release and acupressure on postnatal carpal tunnel syndrome.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 18, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 25, 2025

Completed
2 days until next milestone

Study Start

First participant enrolled

July 27, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 20, 2025

Completed
10 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2025

Completed
Last Updated

July 25, 2025

Status Verified

July 1, 2025

Enrollment Period

3 months

First QC Date

July 18, 2025

Last Update Submit

July 18, 2025

Conditions

Outcome Measures

Primary Outcomes (4)

  • Pain intensity

    The visual analogue scale (VAS) will be used to assess pain intensity before and after intervention. The VAS is usually presented as a 10-cm horizontal line on which the patient's pain intensity is represented by a point between the extremes of "no pain at all" and "worst pain imaginable."

    6 weeks

  • Sensory conduction velocity

    Electromyography device (Tru Trace EMG, 2ch Head box device, manufactured by deymed Diagnostic Pvt., Ltd., Czech Republ) will be used to assess sensory conduction velocity of median nerve before and after the treatment. A pair of ring electrodes will be placed on the index finger for recording, and the sensory nerve will be stimulated antidromically. The stimulating electrodes will be placed at the wrist proximal to carpal tunnel for the distal segment stimulation and at the elbow medial to biceps tendon for the proximal segment stimulation. Conduction velocity is the speed at which the electrical signal travels along the nerve. A reduced velocity can also indicate nerve damage. Its normal range is from 44-60 ms.

    6 weeks

  • Sensory distal latency

    Electromyography device (Tru Trace EMG, 2ch Head box device, manufactured by deymed Diagnostic Pvt., Ltd., Czech Republ) will be used to assess sensory distal latency of median nerve before and after the treatment. A pair of ring electrodes will be placed on the index finger for recording, and the sensory nerve will be stimulated antidromically. The stimulating electrodes will be placed at the wrist proximal to carpal tunnel for the distal segment stimulation and at the elbow medial to biceps tendon for the proximal segment stimulation. The distal motor latency is measured from the onset of the stimulating artifact to the onset of the compound muscle action potential. Its normal range is from 2.5-3.5 ms.

    6 weeks

  • Median nerve amplitude

    The amplitude of the median nerve (specifically, the sensory nerve action potential, or SNAP) will be measured by electromyography (Tru Trace EMG, 2ch Head box device, manufactured by deymed Diagnostic Pvt., Ltd., Czech Republ) during nerve conduction study before and after treatment. It is measured in microvolts (µV) and reflects the number of nerve fibers conducting the electrical signal. During a nerve conduction study, a small electrical stimulus is applied to the median nerve, and the resulting electrical activity is recorded. The amplitude is then measured as the height of the waveform generated by this activity. Its normal value should be at least 6 microvolt (6 µV).

    6 weeks

Secondary Outcomes (1)

  • Assessment of severity of carpal tunnel syndrome symptoms

    6 weeks

Study Arms (2)

Myofascial release technique

EXPERIMENTAL

The participants will receive myofascial release, for 15 minutes, three times per week for 6 weeks (total of 18 sessions), in addition to night splint and home advice.

Other: Night splintOther: Myofascial release techniqueOther: Home advice

Acupressure

EXPERIMENTAL

The participants will receive acupressure on pericardium 6 acupoint (PC-6 point) for 3 minutes, three times per week for 6 weeks (total of 18 sessions), in addition to night splint and home advice.

Other: Night splintOther: AcupressureOther: Home advice

Interventions

All participants will be treated conservatively by wrist splint in a neutral position.

AcupressureMyofascial release technique

The participant will receive myofascial release using M2T blade. It will be applied on the carpal tunnel over and above the wrist creases on the ventral aspect of the forearm for 15 minutes, 3 sessions weekly for 6 weeks (total of 18 sessions).

Myofascial release technique

It will be applied on the pericardium 6 point (PC-6) for 3 minutes, three times per week for 6 weeks (total of 18 sessions). It is located on the palm side of the wrist a couple of inches toward the body in between the two tendons (palmaris longus \& flexor carpi radialis) that run approximately down the center of the forearm.

Acupressure

The participants will be asked to follow important advices like supporting the wrists during activity and ensuring proper posture, avoiding wrist flexion and extension, avoiding hard clutches, holding or carrying objects for a long time, catching with fingers, repetitive hand and wrist movement such as knitting or sewing, driving, activities and hobbies such as golf, tennis, table tennis.

AcupressureMyofascial release technique

Eligibility Criteria

Age25 Years - 35 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Postpartum women with mild to moderate carpal tunnel syndrome (CTS).
  • Their ages will range from 25 to 35 years old.
  • Their body mass index (BMI) will range from 25 to 30 Kg/m2.
  • The electrophysiological evidence of mild or moderate median nerve lesion at wrist (mild: sensory nerve conduction velocity slow on finger/wrist measurement, sensory nerve latency \>3.5 ms, normal terminal motor latency; moderate: sensory potential preserved with motor slowing, distal motor latency to abductor pollicis brevis (APB) \< 6.5 ms)
  • Positive phalen's test.
  • Positive tinel's test.
  • Unilateral or bilateral carpal tunnel affection will be included.

You may not qualify if:

  • History of brachial plexopathy or malignancy.
  • Radial, ulnar neuropathy, proximal median neuropathy or polyneuropathy.
  • Previous wrist surgery or steroid injection for CTS.
  • History of trauma, fracture, deformity or inflammation in the wrist, such as rheumatoid arthritis.
  • Coagulation abnormalities, pregnancy, fever and infections.
  • Skin disease and skin cancer.
  • Spots, birthmarks or tattoos over the work points.
  • Pacemaker and implementable medical devices.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Amr Kamal Abd El-Aal

Cairo, Egypt

Location

MeSH Terms

Conditions

Carpal Tunnel Syndrome

Interventions

Myofascial Release TherapyAcupressure

Condition Hierarchy (Ancestors)

Median NeuropathyMononeuropathiesPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesNerve Compression SyndromesCumulative Trauma DisordersSprains and StrainsWounds and Injuries

Intervention Hierarchy (Ancestors)

MassageTherapy, Soft TissueMusculoskeletal ManipulationsComplementary TherapiesTherapeuticsPhysical Therapy ModalitiesRehabilitation

Study Officials

  • Afaf Botla, Professor

    Cairo University

    STUDY DIRECTOR
  • Soheir El-kosery, Professor

    Cairo University

    STUDY CHAIR

Central Study Contacts

Amr Abd El-Aal, PHD

CONTACT

Amr Abbasy, Professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

July 18, 2025

First Posted

July 25, 2025

Study Start

July 27, 2025

Primary Completion

October 20, 2025

Study Completion

October 30, 2025

Last Updated

July 25, 2025

Record last verified: 2025-07

Locations